Gene Switching — A New Therapeutic Epoch: Discussion Paper

Benz E J jr (1982) New England Journal of Medicine 307, 1515–1516

Benz E J jr Forget B G (1974) Seminars in Hematology 11, 463–523

Charache S Dover G J Smith K D Talbot C C (1982) Blood 60, Suppl. 1: p 44a

Clegg J B Weatherall D J Bodmer W F (1983) Lancet i, 536

Clough D W Kunkel L M Davidson R L (1982) Science 216, 70–73

De Simone J Biel S I Heller P (1978) Proceedings of the National Academy of Sciences of the USA 75, 2937–2940

De Simone J Heller P Biel M Zwiers D (1981) British Journal of Haematology 49, 175–183

De Simone J Heller P Hall P Zwiers D (1982) Proceedings of the National Academy of Sciences of the USA 79, 4428–4431

Ehrlich M Wang R Y H (1981) Science 212, 1350–1357

Felsenfeld G McGhee J (1982) Nature 296, 602–603

Groudine M Eisenman R Weintraub H (1981) Nature 292, 311–317

Jones P A Taylor S M (1980) Cell 20, 85–93

Lancet (1983) i, 36–37

Ley T J Anagnou N P Young N S Nienhuis A W De Simone J Heller P (1983) Lancet i, 467

Ley T J De Simone J Anagnou P (1982) New England Journal of Medicine 307, 1469–1475

Nalbandian R M (1973) In: Sickle Cell Hemoglobin — Molecule to Man. Ed. Murayama M Nalbandian M R . Little. Brown & Co., Boston; pp 60–61

Nalbandian R M (1982) Journal of the American Medical Association 247, 1462–1464

Nalbandian R M Henry R L Nichols B Camp F R jr Wolf P (1971) Obstetrics and Gynecology Survey 26, 185–189

Orkin S H (1983) Nature 301, 108–109

Pembrey M E Weatherall D J (1971) British Journal of Haematology 21, 355

Stamatoyannopoulos G Nienhuis A W eds (1979) Cellular and Molecular Regulation of Hemoglobin Switching. Grune and Stratton, New York; pp 1–792

van der Ploeg L H T Flavell R A (1980) Cell 19, 947–958